Ecstasy (3,4-methylenedioxymethamphetamine)-induced inappropriate antidiuretic hormone secretion
Related Experiment Video
Updated: Jun 30, 2026

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
Published on: February 5, 2018
1Department of Internal Medicine F, Leumit Health Service, Western Galilee, Nahariya, Israel. Raymond.Farah@naharia.health.gov.il
Abstract:
3,4-Methylenedioxymethamphetamine (MDMA), popularly known as the illicit drug "Ecstasy," is an amphetamine derivative that has become widely abused throughout the United States and other industrialized nations. 3,4-Methylenedioxymethamphetamine has an undeserved reputation as a "safe" drug among its users, but MDMA shares the toxicity profile of other amphetamines. Its use may result in lethal cardiovascular, hepatic, metabolic, or neurological toxicity. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is a unique toxicity that may occur after isolated MDMA use. Although the phenomenon is well described in adults, reports of MDMA-induced SIADH and symptomatic hyponatremia in children are rare. We describe a 13-year-old girl who experienced MDMA-induced SIADH with symptomatic hyponatremia. Toxicity of MDMA, in particular, the pathophysiology and treatment of MDMA-induced hyponatremia, is discussed.
More Related Videos
Related Concept Videos
Diabetes Insipidus I: Introduction
Regulation of Water Output
Diabetes Insipidus II: Pathophysiology
Antihypertensive Drugs: Thiazide-Class Diuretics
Physiology of the Genitourinary System III: Urine Concentration and Dilution
Antihypertensive Drugs: Potassium-Sparing Diuretics

